Cue Biopharma Inc.

NASDAQ: CUE · Real-Time Price · USD
0.81
0.02 (2.53%)
At close: Aug 15, 2025, 3:59 PM
0.83
2.48%
After-hours: Aug 15, 2025, 06:54 PM EDT

Cue Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-8.48M -12.26M -9.5M -8.66M -10.17M -12.35M -13.43M -11.01M -13.19M -13.11M -14.59M -10.96M -13.21M -14.26M -8.38M -12.99M -10.28M -12.51M
Depreciation & Amortization
99K 882K -238K 877K 862K 849K 851K 856K 849K 880K 580.05K 539K 384K 303K -2.73M 316K 314K 318K
Stock-Based Compensation
1.26M 1.34M 1.56M 1.58M 1.75M 1.95M 2.07M 2.07M 2.04M 2M 2.11M 2.06M 2.31M 3.01M 2.97M 3.25M 2.85M 2.44M
Other Working Capital
n/a -82K 542K -2.53M -2.02M -990K -1.63M 648K -283K 226K 214.89K 1.12M -1.34M -2.81M -4.62M -1.63M -1.59M -139K
Other Non-Cash Items
3.71M 41K 45K -55K 42K 42K 2.99M 10K 9K -109K -195.78K -59K -128K -71K -6.44M 1.15M 1.13M 1.12M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -2.79M 21K -41K n/a n/a n/a n/a n/a 3.04M -2K -19K -5K
Change in Working Capital
n/a 1.82M -901K -1.27M -2.48M -274K -647K 246K -40K -493K 1.58M 1.54M -2.21M -561K 895.54K 1.65M -3.77M -3.16M
Operating Cash Flow
-3.42M -8.17M -9.03M -7.53M -9.99M -9.78M -10.96M -7.8M -10.37M -10.83M -10.51M -6.87M -12.85M -11.57M -10.65M -6.63M -9.77M -11.79M
Capital Expenditures
-27K -150K -2K 1K -10K -55K n/a n/a n/a -2K -746 -78K -65K -27K -39 -13K -252K -648K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a 2K 205.00 3K 3K n/a 10M 2K 19K n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a -149K -336 -29.45M n/a n/a 419.00 n/a n/a -5K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a 5M 5M 15M 5M 29.44M n/a n/a -10M n/a n/a 10M
Other Investing Acitivies
n/a n/a 1K 97K n/a n/a n/a n/a 5M 151K 5M -29.44M 3K n/a 131.00 2K 19K 5K
Investing Cash Flow
-27K -150K -1K 98K -10K -55K n/a 5M 5M 15M 5M -29.52M -62K -27K 511.00 -11K -233K 9.35M
Debt Repayment
n/a -1M -999K -1M -1M -1M -1M -1M n/a n/a n/a n/a n/a 10M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -9K n/a -191K n/a -482K n/a -85K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
17.8M n/a 14.24M n/a n/a n/a n/a n/a 85K 388K 27.4M -9K n/a -333K 354.65K 351K 309K 919K
Financial Cash Flow
17.8M -1M -932K 9.82M -1M 2.35M 4.78M 4.59M 2.1M 388K 27.4M -9K 11.11M 15.16M 7.38M 351K 10.67M 834K
Net Cash Flow
14.36M -9.32M -9.96M 2.39M -11M -7.49M -6.18M 1.79M -3.27M 4.56M 21.89M -36.4M -1.8M 3.56M -3.26M -6.29M 663K -1.61M
Free Cash Flow
-3.44M -8.32M -9.03M -7.53M -10M -9.84M -10.96M -7.8M -10.37M -10.84M -10.51M -6.95M -12.91M -11.6M -10.65M -6.64M -10.02M -12.44M